| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |